ARAVIVE BIOLOGICS INC has a total of 16 patent applications. It increased the IP activity by 700.0%. Its first patent ever was published in 2013. It filed its patents most often in Australia, United States and Canada. Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are CHILDREN S HOSPITAL LOS ANGELE, ENTRADA THERAPEUTICS INC and LEVETAN CLARESA.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 5 | |
#2 | United States | 3 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | China | 1 | |
#6 | Hong Kong | 1 | |
#7 | Republic of Korea | 1 | |
#8 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Enzymes | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Giaccia Amato J | 8 |
#2 | Kariolis Mihalis | 8 |
#3 | Tabibiazar Ray | 7 |
#4 | Prohaska David | 7 |
#5 | Mcintyre Gail | 7 |
#6 | Tabibiazar Raymond | 6 |
#7 | Miao Yu Rebecca | 5 |
#8 | Cochran Jennifer R | 3 |
#9 | Miao Yu | 3 |
#10 | Jones Douglas | 3 |
Publication | Filing date | Title |
---|---|---|
KR20200085307A | Method of treatment of metastatic cancer using AXL attractant receptor | |
AU2015364437A1 | Antifibrotic activity of GAS6 inhibitor | |
US2016206705A1 | Antiviral activity of Gas6 inhibitor |